A european phase II study of recombinant human granulocyte colony- stimulating factor (lenograstim) in the treatment of severe chronic neutropenia in children

European Journal of Pediatrics

Volumn 156, Issue 9, 1997, Pages 693-700

  Donadieu, J ^a   Boutard, P ^b   Bernatowska, E ^c   Tchernia, G ^d   Couillaud, G ^e   Philippe, N ^d   Le Gall, E ^f  

^a CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

^c CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^d HÔPITAL DEBROUSSE   (France)

^e HÔPITAL DU BOCAGE   (France)

^f SERVICE DE RHUMATOLOGIE   (France)

Author keywords

CFU GM; Lenograstim; Phase II study; Severe chronic neutropenia

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; BONE PAIN; CHILD; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COLONY FORMING UNIT GM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; GRANULOPOIESIS; HUMAN; INFANT; INFECTION RESISTANCE; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY OF LIFE; SCHOOL CHILD; SPLENOMEGALY; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COLONY-FORMING UNITS ASSAY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HUMANS; INFANT; MALE; NEUTROPENIA; NEUTROPHILS; OPPORTUNISTIC INFECTIONS; PROSPECTIVE STUDIES; QUALITY OF LIFE; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 0030882898     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310050692     Document Type: Article

References (21)

1. Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, Thomas M (1983) Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol 130:1910-1917
2. Bonilla MA, Gillio AP, Ruggeiro M, Kernan N, Brochstein J, Aboud M, Fumagalli L, Vincent M, Gabrilove J, Welete K, Souza L, O'Reilly R (1989) Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital neutropenia. N Engl J Med 320:1574-1580
3. Bonilla MA, Dale D, Zeidler C, Last L, Reiter A, Ruggeiro M, Davis M, Koci B, Hammond W, Gillio A, Welte K (1994) Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias. Br J Haematol 88:723-730
4. Cleary PD, Morissey G, Yver A, Oster G (1994) The effects of rG-CSF on health related quality of life in children with congenital agranulocytosis. Qual Life Res 3:307-315
5. Coulombel L, Morardet N, Veber F, Leroy C, Mielot F, Fischer A, Teillet-Thiebaud F, Tchernia G, Griscelli C, Parmentier C (1988) Granulocyte differentiation in long term bone marrow cultures from children with congenital agranulocytosis. Am J Hematol 27:93-98
6. Coulombel L, Vuillet MH, Leroy C, Tchernia G (1988) Lineage-and stage-specific adhesion of human hematopoeitic progenitor cells to extracellular matrices from marrow fibroblasts. Blood 71:329-334
7. Dale DC, Bonilla MA, Davis MW, Nakanishi AM, Hammond WP, Kurztberg J, Wang W, Jakubowski A, Winton E, Lalezari P, Robinson W, Glaspy JA, Emerson S, Gabrilove J, Vincent M, Boxer LA (1993) A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 81:2496-2502
8. Dale DC, Cottle T, Bolyard AA, Fier C, Bonilla MA, Boxer L, Brown SL, Cham B, Freedman M, Kannourakis G, Welte K (1995) Severe chronic neutropenia: report on treatment and outcome from an new international registry. (abstract) Blood [Suppl]:1686
9. Donadieu J, Boutard P, Tchernia G, Oster G, Gordon-Smith EC, Philippe N, Le Gall E, Nivelon JL, Dopfer R, Babin-Boilletot A, Coulombel L, Pocidalo MA, Yver A, Griscelli C (1994) A phase II study of recombinant human granulocyte colony-stimulating factor (rHuG-CSF; lenograstim) in the treatment of agranulocytosis in children. Nouv Rev Fr Hematol 36:441-448
10. Dong F, Brynes RK, Tidow N, Welte K, Löwenberg B, Touw IP (1995) Mutations in the gene for granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Engl J Med 333:487-493
11. Gisselbrecht C, Prentice HG, Bacigalupo A, Biron P, Milpied N, Rubie H, Cunningham D, Legros M, Pico JL, Linch DC, Burnett AK, Scarffe JH, Siegert W, Yver A (1994) Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation. Lancet 343:696-700
12. Jones EA, Bolyard AA, Dale DC (1993) Quality of life of patients with severe chronic neutropenia receiving long term treatment with granuclocyte colony-stimulating factor. JAMA 270:1132-1133
13. Kearns CM, Wang WC, Stute N, Ihle JN, Evans WE (1993) Disposition of recombinant human granulocyte colony stimulating factor in children with severe chronic neutropenia. J Pediatr 123:471-479
14. Khwaja A, Karver JE, Linch DC (1992) Interaction of G-CSF and TNF α in the priming of the neutrophil respiratory burst. Blood 79:745-754
15. Kostmann R (1975) Infantile genetic agranulocytosis. Acta Paediatr Scand 64:362-368
16. Kubota N, Orita T, Hattori K, Oh-eda M, Ochi N, Yamazachi T (1990) Structural characterization of natural and recombinant human granulocyte colony-stimulating factors. J Biol Chem 107:486-492
17. Luna-Fineman S, Shannon KM, Lange BJ (1995) Childhood monosomy 7: epidemiology, biology, and mechanistic implications. Blood 85:1985-1999
18. Parmley RT, Ogawa M, Darby CP, Spicer SS (1975) Congenital neutropenia: neutrophil proliferation with abnormal maturation. Blood 46:723-734
19. Pincus SH, Boxer LA, Stossel TP (1976) Chronic neutropenia in childhood. Analysis of 16 cases and a review of the literature. Am J Med 61:849-861
20. Weinblatt ME, Scimeca P, James-Herry A, Sahdev I, Kochen J (1995) Transformation of congenital neutropenia into monosomy 7 and acute nonlymphoblastic leukemia in a child treated with granulocyte colony-stimulating factor. J Pediatr 126:263-265
21. Woermann UJ, Schenk R, Zimmerman A, Tobler A (1993) Increased bone metabolism in a patient undergoing long-term rhG-CSF treatment for idiopathic acquired neutropenia. Ann Hematol 66:267-268